Elimination of myotonia improves myopathy in a muscleblind knockout model of myotonic dystrophy
Matthew T. SippleiD, Sakura A. HamazakiiD, Vanessa TodorowiD, Lily A. CiscoiD, Katherine M Lupia, Christina S. HeiliD, Peter MeinkeiD, Charles A. ThorntoniD, John D. LueckiD
Abstract
A cardinal sign of myotonic dystrophy type 1 (DM1) is slow of muscle relaxation after voluntary contraction known as myotonia. Myotonia results from mis-regulated splicing of chloride channel 1 (ClC-1), leading to loss of channel function and runs of involuntary action potentials in muscle fibers. Heralding the onset of weakness, myotonia is often the first symptom of DM1, and raising the possibility that muscle hyperexcitability promotes the subsequent development of myopathy. We used genome editing to test this possibility by deleting the alternatively spliced and frameshift inducing ClC-1 exon 7a (E7a) in the Mbnl1 knockout model of DM1. Although several ClC-1 exons exhibit mis-regulated splicing in DM1, deletion of this single cryptic exon was sufficient to restore ClC-1 function and eliminate myotonia systemically and permanently. As determined by long-read sequencing, deletion of E7a reduced the frequency of other splicing defects in ClC-1 transcripts, likely as a passive consequence of restoring reading frame and nonsense surveillance. Furthermore, we observed significantly improved muscle force generation, fiber-type distribution, and histology, and partial restoration of the muscle transcriptome, including differential gene expression and alternative splicing, in non-myotonic Mbnl1 knockout mice. These results suggest that E7a inclusion is a lynchpin splice event that contributes to skeletal myopathy, highlighting myotonia as a therapeutic target and an outcome of interest in DM1. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=171 SRC="FIGDIR/small/677400v1_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@101b333org.highwire.dtl.DTLVardef@9be92corg.highwire.dtl.DTLVardef@1e95c88org.highwire.dtl.DTLVardef@1b9eeee_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Patient-derived 3D engineered human muscle model recapitulates CLCN1 mis-splicing and myotonia in myotonic dystrophy type 1
Xiomara Fernández‐Garibay, María Sabater-Arcis, … Juan M. Fernández‐Costa·bioRxiv·Feb 5, 2026
- Combinatorial chloride and calcium channelopathy in myotonic dystrophy
L. A. Cisco, M. T. Sipple, … J. D. Lueck·bioRxiv·May 29, 2023
- Alternative splicing of SORBS1 affects neuromuscular junction formation and stability in myotonic dystrophy type 1
Caroline Hermitte, Hortense de Calbiac, … Morgan Gazzola·bioRxiv·Dec 23, 2024
- Deregulations of miR-1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1
Anissa Souidi, Masayuki Nakamori, … Krzysztof Jagla·EMBO ReportsPeer-reviewed·Feb 28, 2023
- Co-opting MBNL-dependent alternative splicing cassette exons to control gene therapy in myotonic dystrophy
Samuel Carrell, Ellie M. Carrell, … Beverly L. Davidson·Annals of NeurologyPeer-reviewed·Aug 29, 2025
- Overexpression of a non-muscle RBFOX2 isoform triggers cardiac conduction defects in myotonic dystrophy
Chaitali Misra, Sushant Bangru, … Auinash Kalsotra·Developmental CellPeer-reviewed·Feb 27, 2020